Alembic Pharma

Market Cap: Mid Cap
Industry: Pharmaceuticals & Drugs
ISIN: INE901L01018
NSEID: APLLTD
BSEID: 533573

INR

840.00

1.5 (0.18%)

BSENSE

Apr 11, 12:53 PM

BSE+NSE Vol: 87.77 k

{
  "main_header": {
    "sid": 807696,
    "name": "Alembic Pharma",
    "stock_name": "Alembic Pharma",
    "full_name": "Alembic Pharmaceuticals Ltd.",
    "name_url": "stocks-analysis/alembic-pharma",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "840.00",
    "chg": 1.5,
    "chgp": "0.18%",
    "dir": 1,
    "prev_price": "838.50",
    "mcapval": "16,511.30 Cr",
    "mcap": "Mid Cap",
    "scripcode": 533573,
    "symbol": "APLLTD",
    "ind_name": "Pharmaceuticals & Drugs",
    "ind_code": 4,
    "isin": "INE901L01018",
    "curr_date": "Apr 11, 12:53 PM",
    "curr_time": "01:26 AM",
    "bse_nse_vol": "87.77 k",
    "exc_status": "Active",
    "traded_date": "Apr 11, 2025",
    "traded_date_str": "2025 04 11",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://sandbox-www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/alembic-pharma-807696-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Alembic Pharmaceuticals Faces Mixed Financial Indicators Amid Technical Shift in Stock Trend",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/alembic-pharmaceuticals-stock-upgraded-to-sell-amid-declining-operating-profit-1573112",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/3/AlembicPharmace_mojoScore_770876.png",
        "date": "2025-03-24 08:07:13",
        "description": "Alembic Pharmaceuticals has recently experienced an evaluation adjustment, indicating a shift in its technical indicators. While the stock has outperformed the Sensex over the past week, its year-to-date performance shows a decline. The company's financial health is mixed, with strong debt servicing ability but declining operating profit and recent profit after tax."
      },
      {
        "title": "Alembic Pharmaceuticals Faces Technical Trend Challenges Amid Market Volatility",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/alembic-pharmaceuticals-technical-trend-shifts-from-bearish-to-mildly-bearish-amid-stock-price-increase-1572958",
        "imagepath": "",
        "date": "2025-03-24 08:01:52",
        "description": "Alembic Pharmaceuticals, a midcap player in the Pharmaceuticals & Drugs industry, has recently undergone an evaluation revision reflecting its current market dynamics. The stock is currently priced at 947.75, showing a notable increase from the previous close of 833.30. Over the past year, Alembic Pharma has experienced a 52-week high of 1,296.15 and a low of 725.60, indicating significant volatility.\n\nIn terms of technical indicators, the weekly MACD remains bearish, while the monthly outlook is mildly bearish. The Relative Strength Index (RSI) shows no signal for both weekly and monthly assessments. Bollinger Bands indicate a mildly bearish trend on a weekly basis, while the monthly trend is sideways. Daily moving averages also reflect a mildly bearish sentiment.\n\nWhen comparing the company's performance to the Sensex, Alembic Pharmaceuticals has shown a strong return over the past week and month, outperf..."
      },
      {
        "title": "Alembic Pharmaceuticals Outperforms Sector Amid Broader Market Recovery Trends",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/alembic-pharmaceuticals-stock-rises-5-35-outperforming-market-despite-mixed-performance-indicators-1549588",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/3/AlembicPharmace_priceRelatedfactors_757141.png",
        "date": "2025-03-21 12:15:53",
        "description": "Alembic Pharmaceuticals has experienced significant stock activity, outperforming its sector and reaching an intraday high. While it shows mixed trends in moving averages, the broader market has also seen a recovery, with small-cap stocks leading. However, Alembic's longer-term performance indicates a decline compared to the Sensex."
      },
      {
        "title": "Alembic Pharmaceuticals Shows Strong Short-Term Gains Amid Mixed Long-Term Trends",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/alembic-pharmaceuticals-stock-rises-5-66-amid-broader-market-decline-1233918",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/3/AlembicPharmace_priceRelatedfactors_629523.png",
        "date": "2025-03-07 13:15:51",
        "description": "Alembic Pharmaceuticals has experienced notable activity, gaining 5.66% on March 7, 2025, and outperforming its sector. The stock has shown a strong upward trend over the past five days, despite facing challenges in the previous month. Its performance reflects a complex market landscape with mixed long-term indicators."
      },
      {
        "title": "Alembic Pharmaceuticals Outperforms Sector Amid Broader Market Decline and Volatility",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/alembic-pharmaceuticals-rises-7-25-amid-broader-market-decline-1180638",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/3/AlembicPharmace_priceRelatedfactors_566616.png",
        "date": "2025-03-04 11:05:20",
        "description": "Alembic Pharmaceuticals has demonstrated strong performance, gaining 7.25% on March 4, 2025, and outperforming its sector. The stock has seen consecutive gains over two days, while the broader market, represented by the Sensex, is experiencing a bearish trend and nearing its 52-week low."
      },
      {
        "title": "Alembic Pharmaceuticals Hits 52-Week Low Amid Ongoing Market Challenges",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/alembic-pharmaceuticals-hits-52-week-low-at-rs-730-3-amid-ongoing-decline-1171304",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/3/AlembicPharmace_priceRelatedfactors_561604.png",
        "date": "2025-03-03 09:37:08",
        "description": "Alembic Pharmaceuticals has reached a new 52-week low, continuing a downward trend with eight consecutive days of decline, totaling a 9.83% drop. The stock is trading below key moving averages and has decreased by 29.76% over the past year, contrasting with the Sensex's minor dip."
      },
      {
        "title": "Alembic Pharmaceuticals Faces Continued Decline Amid Broader Market Trends and Challenges",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/alembic-pharmaceuticals-hits-52-week-low-amid-continued-stock-decline-1140106",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/2/AlembicPharmace_priceRelatedfactors_547783.png",
        "date": "2025-02-28 09:38:22",
        "description": "Alembic Pharmaceuticals has faced notable volatility, hitting a new 52-week low and declining for seven consecutive days, with a total drop of 7.48%. The stock remains below key moving averages and has decreased by 26.20% over the past year, contrasting with the Sensex's modest gain."
      },
      {
        "title": "Alembic Pharmaceuticals Hits 52-Week Low Amidst Ongoing Market Challenges",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/alembic-pharmaceuticals-hits-52-week-low-at-rs-772-4-amid-sustained-decline-1128981",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/2/AlembicPharmace_priceRelatedfactors_527049.png",
        "date": "2025-02-27 09:35:58",
        "description": "Alembic Pharmaceuticals has reached a new 52-week low, reflecting ongoing challenges as it underperforms its sector. The company has faced consecutive losses over the past six days, with a significant decline over the past year, contrasting sharply with broader market gains. Future strategies will be closely monitored."
      },
      {
        "title": "Alembic Pharmaceuticals Hits 52-Week Low Amidst Broader Market Challenges",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/alembic-pharmaceuticals-hits-52-week-low-at-rs-784-1-amid-23-90-annual-decline-1108077",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/2/AlembicPharmace_priceRelatedfactors_510142.png",
        "date": "2025-02-25 09:49:34",
        "description": "Alembic Pharmaceuticals has reached a new 52-week low, following four days of price declines. Despite a slight recovery today, the stock has dropped 23.90% over the past year, underperforming the Sensex. It is currently trading below its moving averages, indicating ongoing challenges in the market."
      }
    ],
    "total": 2826,
    "sid": "807696",
    "stock_news_url": "https://sandbox-www.marketsmojo.com/news/alembic-pharmaceuticals-807696"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "09-Apr-2025",
      "details": "Please find attached herewith a copy of advertisement related to notice of loss of equity share certificate.",
      "source": "BSE"
    },
    {
      "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
      "datetime": "04-Apr-2025",
      "details": "Please find enclosed herewith the Certificate under Regulation 74(5) of SEBI (DP) Regulations",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "03-Apr-2025",
      "details": "Please find attach herewith a copy of advertisement related to notice of loss of share certificate published by the Company.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Alembic Pharmaceuticals Ltd. has declared <strong>550%</strong> dividend, ex-date: 15 Jul 24",
          "dt": "2024-07-15",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Alembic Pharmaceuticals Faces Mixed Financial Indicators Amid Technical Shift in Stock Trend

2025-03-24 08:07:13

Alembic Pharmaceuticals has recently experienced an evaluation adjustment, indicating a shift in its technical indicators. While the stock has outperformed the Sensex over the past week, its year-to-date performance shows a decline. The company's financial health is mixed, with strong debt servicing ability but declining operating profit and recent profit after tax.

Alembic Pharmaceuticals Faces Technical Trend Challenges Amid Market Volatility

2025-03-24 08:01:52

Alembic Pharmaceuticals, a midcap player in the Pharmaceuticals & Drugs industry, has recently undergone an evaluation revision reflecting its current market dynamics. The stock is currently priced at 947.75, showing a notable increase from the previous close of 833.30. Over the past year, Alembic Pharma has experienced a 52-week high of 1,296.15 and a low of 725.60, indicating significant volatility. In terms of technical indicators, the weekly MACD remains bearish, while the monthly outlook is mildly bearish. The Relative Strength Index (RSI) shows no signal for both weekly and monthly assessments. Bollinger Bands indicate a mildly bearish trend on a weekly basis, while the monthly trend is sideways. Daily moving averages also reflect a mildly bearish sentiment. When comparing the company's performance to the Sensex, Alembic Pharmaceuticals has shown a strong return over the past week and month, outperf...

Alembic Pharmaceuticals Outperforms Sector Amid Broader Market Recovery Trends

2025-03-21 12:15:53

Alembic Pharmaceuticals has experienced significant stock activity, outperforming its sector and reaching an intraday high. While it shows mixed trends in moving averages, the broader market has also seen a recovery, with small-cap stocks leading. However, Alembic's longer-term performance indicates a decline compared to the Sensex.

Alembic Pharmaceuticals Shows Strong Short-Term Gains Amid Mixed Long-Term Trends

2025-03-07 13:15:51

Alembic Pharmaceuticals has experienced notable activity, gaining 5.66% on March 7, 2025, and outperforming its sector. The stock has shown a strong upward trend over the past five days, despite facing challenges in the previous month. Its performance reflects a complex market landscape with mixed long-term indicators.

Alembic Pharmaceuticals Outperforms Sector Amid Broader Market Decline and Volatility

2025-03-04 11:05:20

Alembic Pharmaceuticals has demonstrated strong performance, gaining 7.25% on March 4, 2025, and outperforming its sector. The stock has seen consecutive gains over two days, while the broader market, represented by the Sensex, is experiencing a bearish trend and nearing its 52-week low.

Alembic Pharmaceuticals Hits 52-Week Low Amid Ongoing Market Challenges

2025-03-03 09:37:08

Alembic Pharmaceuticals has reached a new 52-week low, continuing a downward trend with eight consecutive days of decline, totaling a 9.83% drop. The stock is trading below key moving averages and has decreased by 29.76% over the past year, contrasting with the Sensex's minor dip.

Alembic Pharmaceuticals Faces Continued Decline Amid Broader Market Trends and Challenges

2025-02-28 09:38:22

Alembic Pharmaceuticals has faced notable volatility, hitting a new 52-week low and declining for seven consecutive days, with a total drop of 7.48%. The stock remains below key moving averages and has decreased by 26.20% over the past year, contrasting with the Sensex's modest gain.

Alembic Pharmaceuticals Hits 52-Week Low Amidst Ongoing Market Challenges

2025-02-27 09:35:58

Alembic Pharmaceuticals has reached a new 52-week low, reflecting ongoing challenges as it underperforms its sector. The company has faced consecutive losses over the past six days, with a significant decline over the past year, contrasting sharply with broader market gains. Future strategies will be closely monitored.

Alembic Pharmaceuticals Hits 52-Week Low Amidst Broader Market Challenges

2025-02-25 09:49:34

Alembic Pharmaceuticals has reached a new 52-week low, following four days of price declines. Despite a slight recovery today, the stock has dropped 23.90% over the past year, underperforming the Sensex. It is currently trading below its moving averages, indicating ongoing challenges in the market.